Blackstone closing in on Aurobindo's injectables business

The keenly contested transaction, now in the final stages of negotiations, pits Blackstone against Baring Private Equity Asia, the only other contender still in the fray and is likely to see listed Aurobindo getting split into two.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rC9lgyT
via IFTTT